INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
26/11/2023
Voltar para busca
Dado oficial do USPTO
CERTAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
26/11/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
03/08/2011
Data de registro
04/09/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2023
Última transação
18/02/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Hilden, DE
Examinador
STRUCK, ROBERT J
Unidade examinadora
L90
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
QIAGEN GmbH
QIAGEN GmbH
Representantes
Victoria Friedman Dennemeyer & Associates, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemical and biotechnological products used in industry and sciencenucleic acidsenzymespolymerasesreagents for staining and markingmolecular probesbufferaqueous and non-aqueous solutions of alcohols and saltsdistilled and purified watersilica in powderedgranulate and gel form and magnetic particles in fluid formreagents and solvents for sample preparationthe modification and manipulation of cellsfor conducting markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesfor identifying contamination through biomolecules; namelyreagents for research purposes; kits containing chemicals for sample preparationthe modification and manipulation of cellsfor the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample material for laboratory or research use
Classe 5
Diagnostic preparations for medical purposes; diagnostic preparations for medical and veterinary usein particular for sample preparationthe modification and manipulation of cellsfor conducting the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substanceschemicalbiochemical and biotechnological preparationsin particular diagnostic reagents and solvents for medical and veterinary use for sample preparationthe modification and manipulation of cellsfor conducting markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis methods for biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; kits containing medical and veterinary diagnostic preparationsin particular for sample preparationthe modification and manipulation of cellsfor the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample material
Classe 9
Scientific apparatusinstruments and equipmentin particular for research and experimentation purposeslaboratory apparatusmeasuring apparatus and instruments in the nature of chromatography columnsrobots and preprogrammed smart cards for proteinDNA and RNA purification protocolsfor the use of medical and veterinary diagnostic preparationsin particular for sample preparationthe modification and manipulation of cellsfor the markingseparatingidentifyingquantifyingisolatingpurifyingduplicating and/or analysis of biopolymersfor identifying contamination through biomoleculesin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids from biological or biochemical sample materialall the aforesaid goods included in this class
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
25/10/2023
INPC
INVALIDATION PROCESSED
25/10/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
18/10/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
19/02/2023
71AG
REGISTERED-SEC.71 ACCEPTED
18/02/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/02/2023
ES71
TEAS SECTION 71 RECEIVED
08/08/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/09/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
19/08/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
18/10/2019
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
26/07/2019
INPC
INVALIDATION PROCESSED
26/07/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/06/2019
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
11/10/2018
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
11/10/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/09/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
31/08/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/09/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/12/2012
GPNX
NOTIFICATION PROCESSED BY IB
10/12/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/12/2012
FIMP
FINAL DISPOSITION PROCESSED
05/12/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/12/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/06/2012
PUBO
PUBLISHED FOR OPPOSITION
19/06/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/05/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/05/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/05/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/05/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/05/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
15/05/2012
ALIE
ASSIGNED TO LIE
15/05/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/05/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
14/05/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/05/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/04/2012
GNFR
FINAL REFUSAL E-MAILED
12/04/2012
CNFR
FINAL REFUSAL WRITTEN
12/04/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/03/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/03/2012
RFNT
REFUSAL PROCESSED BY IB
24/12/2011
MAFR
APPLICATION FILING RECEIPT MAILED
09/12/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/12/2011
RFRR
REFUSAL PROCESSED BY MPU
07/12/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/12/2011
CNRT
NON-FINAL ACTION WRITTEN
06/12/2011
DOCK
ASSIGNED TO EXAMINER
05/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/12/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CERTAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.